ミネソタ州における前立腺がんの臨床試験
ミネソタ州内の拠点で、前立腺がんに関する48件の研究が参加者を募集しています。
ミネソタ州内の都市
- Minneapolis23件の研究
- Rochester22件の研究
- Saint Paul13件の研究
- Duluth7件の研究
- Saint Cloud6件の研究
- Brooklyn Park6件の研究
- Bloomington6件の研究
- Plymouth6件の研究
公式研究テキスト（英語）
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
被験者募集中第3相
18歳以上 · 男性 · 2026/10/02更新 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- 他48件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Essentia Health Cancer Center, Duluth
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06632977A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Health Partners Frauenshuh Cancer Center, Saint Louis Park
- Health Partners Cancer Center at Regions Hospital, Saint Paul
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Essentia Health - Deer River Clinic, Deer River
- Essentia Health Cancer Center, Duluth
- Fairview Southdale Hospital, Edina
- 他8件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- University Of Minnesota, Minneapolis
被験者募集中第1相
18歳以上 · 男性 · 2026/09/28更新 · NCT06095089Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- M Health Fairview Clinics and Surgery Center, Minneapolis
被験者募集中第1相
18歳以上 · 男性 · 2026/09/25更新 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Avera Cancer Institute - Marshall ( Site 0122), Marshall
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park
- HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092), Saint Paul
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06136650A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
被験者募集中第3相
18歳以上 · 男性 · 2026/09/22更新 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Rochester
被験者募集中第3相
18歳以上 · 男性 · 2026/09/18更新 · NCT06952803Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳以上 · 男性 · 2026/09/18更新 · NCT07650240A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Rochester
被験者募集中第1/2相
18歳以上 · 男性 · 2026/09/18更新 · NCT06990880Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
被験者募集中第2相
18歳以上 · 男性 · 2026/09/17更新 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital ( Site 0052), Saint Paul
被験者募集中第3相
18歳以上 · 男性 · 2026/09/17更新 · NCT06925737Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Mayo Clinic, Rochester
被験者募集中
18歳以上 · 男性 · 2026/09/14更新 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Mayo Clinic- Rochester, Rochester
被験者募集中第3相
18歳以上 · 男性 · 2026/09/11更新 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Minnesota Oncology Hematology PA-Chaska, Chaska
- 他16件
被験者募集中第3相
18歳以上 · 男性 · 2026/09/10更新 · NCT05946213The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Minneapolis
被験者募集中第1/2相
18歳〜99歳 · 男性 · 2026/08/27更新 · NCT07590934A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Masonic Cancer Center, Minneapolis
被験者募集中第2相
18歳以上 · 男性 · 2026/08/21更新 · NCT06844383Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Minnesota Oncology - Burnsville, Burnsville
- Minnesota Oncology Hematology PA-Chaska, Chaska
- Mercy Hospital, Coon Rapids
- 他21件
被験者募集中第3相
18歳以上 · 男性 · 2026/08/19更新 · NCT04423211Water Vapor Ablation for Prostate Cancer: Long-Term Registry
- Minnesota Urology, Woodbury
被験者募集中観察研究
全年齢 · 男性 · 2026/08/18更新 · NCT07455058FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
被験者募集中第1相
18歳〜100歳 · 男性 · 2026/08/13更新 · NCT05519449Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Mayo Clinic Health System-Mankato, Mankato
- Mayo Clinic in Rochester, Rochester
被験者募集中
18歳以上 · 男性 · 2026/07/30更新 · NCT06325046MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
- Mayo Clinic in Rochester, Rochester
被験者募集中
45歳〜80歳 · 男性 · 2026/07/22更新 · NCT05438563Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Mayo Clinic in Rochester, Rochester
被験者募集中第2相
18歳以上 · 男性 · 2026/07/20更新 · NCT06378866Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- 他18件
被験者募集中第3相
18歳以上 · 男性 · 2026/07/14更新 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Mayo Clinic, Rochester
被験者募集中第1相
18歳以上 · 男性 · 2026/07/09更新 · NCT07103018Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Minnesota Oncology Hematology, Minneapolis
被験者募集中第1相
18歳以上 · 男性 · 2026/07/09更新 · NCT05413421Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- University of Minnesota, Minneapolis
被験者募集中第1相
18歳以上 · 男性 · 2026/07/02更新 · NCT07140900Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- 他2件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Mayo Clinic in Rochester, Rochester
被験者募集中健康なボランティア歓迎
18歳〜85歳 · 全性別 · 2026/06/10更新 · NCT06788886Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Mayo Clinic Rochester, Rochester
被験者募集中第4相
18歳〜100歳 · 男性 · 2026/06/04更新 · NCT05803941A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Rochester
被験者募集中第1相
18歳以上 · 男性 · 2026/05/12更新 · NCT06879041Axelopran for Advanced Cancer in Patients Receiving Opioids
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/05更新 · NCT07354919Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/17更新 · NCT06315595A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519Screening and Staging of Benign vs Malignant Pelvic Abnormalities
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/02/17更新 · NCT07407959ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。